Cargando…

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy

OBJECTIVE: This study aimed to directly compare the effectiveness of first‐line monotherapy levetiracetam (LEV) versus enzyme‐inducing antiseizure medications (EIASMs) in glioma patients. METHODS: In this nationwide retrospective observational cohort study, Grade 2–4 glioma patients were included, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meer, Pim B., Maschio, Marta, Dirven, Linda, Taphoorn, Martin J. B., Koekkoek, Johan A. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100008/ https://www.ncbi.nlm.nih.gov/pubmed/36380710 http://dx.doi.org/10.1111/epi.17464

Ejemplares similares

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

Depression and anxiety in glioma patients
por: van der Meer, Pim B, et al.
Publicado: (2023)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Levetiracetam in the treatment of epilepsy
por: Abou-Khalil, Bassel
Publicado: (2008)

Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2022)

Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters
por: Shvarts, Vladimir, et al.
Publicado: (2013)

Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
por: CHONAN, Masashi, et al.
Publicado: (2020)

Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014)

Levetiracetam in the treatment of childhood epilepsy
por: Wheless, James W
Publicado: (2007)

Efflux dynamics of the antiseizure drug, levetiracetam, through the P-glycoprotein channel revealed by advanced comparative molecular simulations
por: Behmard, Esmaeil, et al.
Publicado: (2022)

Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

Clinical Evaluation of Levetiracetam in the Treatment of Epilepsy
por: Wu, Haohao, et al.
Publicado: (2022)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Presurgical cognitive status in patients with low‐grade glioma and epilepsy: Testing the effects of seizures, antiseizure medications, and tumor localization
por: Guarracino, Ilaria, et al.
Publicado: (2022)

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy
por: Posar, Annio, et al.
Publicado: (2014)

Mechanisms of Levetiracetam in the Control of Status Epilepticus and Epilepsy
por: Deshpande, Laxmikant S., et al.
Publicado: (2014)

Retracted: Clinical Evaluation of Levetiracetam in the Treatment of Epilepsy
por: Healthcare Engineering, Journal of
Publicado: (2023)

Advance Care Planning in Glioblastoma Patients
por: Fritz, Lara, et al.
Publicado: (2016)

Influence of Different Antiseizure Medications on Vascular Risk Factors in Children with Epilepsy
por: Mahrous, Doaa M., et al.
Publicado: (2022)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
por: Willems, Laurent M., et al.
Publicado: (2023)

Effect of Levetiracetam Monotherapy on Liver Enzymes and Creatine Kinase Concentrations in Children with Epilepsy: A Prospective Study
por: Attilakos, Achilleas, et al.
Publicado: (2018)

The efficacy and side effects of levetiracetam on refractory epilepsy in children
por: Incecik, Faruk, et al.
Publicado: (2012)

Neurobehavioral Effects of Levetiracetam in Brain Tumor Related Epilepsy
por: Bernett, Abigail, et al.
Publicado: (2013)

Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review
por: Weijenberg, Amerins, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pc3otu7er8j0bsbfl0q9s8n1n9